| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell, alpha-beta | 46 | 2024 | 812 | 8.220 |
Why?
|
| Receptors, Antigen, T-Cell | 132 | 2024 | 2568 | 6.300 |
Why?
|
| T-Lymphocytes | 238 | 2024 | 10266 | 4.400 |
Why?
|
| Major Histocompatibility Complex | 40 | 2024 | 877 | 3.610 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 68 | 2008 | 897 | 3.250 |
Why?
|
| Mechanotransduction, Cellular | 12 | 2024 | 541 | 3.150 |
Why?
|
| Thymus Gland | 54 | 2022 | 1266 | 2.880 |
Why?
|
| Lymphocyte Activation | 109 | 2024 | 5505 | 2.530 |
Why?
|
| HIV Envelope Protein gp41 | 15 | 2023 | 306 | 2.460 |
Why?
|
| Epitopes, T-Lymphocyte | 20 | 2021 | 827 | 2.200 |
Why?
|
| Peptides | 44 | 2024 | 4354 | 2.100 |
Why?
|
| Receptors, Immunologic | 51 | 1997 | 1418 | 2.040 |
Why?
|
| Antigens, Surface | 91 | 2021 | 1617 | 1.980 |
Why?
|
| Histocompatibility Antigens | 12 | 2024 | 479 | 1.760 |
Why?
|
| T-Lymphocytes, Cytotoxic | 30 | 2018 | 1801 | 1.710 |
Why?
|
| Influenza A virus | 9 | 2024 | 460 | 1.690 |
Why?
|
| Histocompatibility Antigens Class II | 28 | 2021 | 1441 | 1.660 |
Why?
|
| Amino Acid Sequence | 111 | 2021 | 13421 | 1.570 |
Why?
|
| T-Lymphocyte Subsets | 14 | 2017 | 1815 | 1.510 |
Why?
|
| CD8-Positive T-Lymphocytes | 19 | 2024 | 4648 | 1.410 |
Why?
|
| Molecular Sequence Data | 112 | 2015 | 17622 | 1.350 |
Why?
|
| Histocompatibility Antigens Class I | 10 | 2022 | 1361 | 1.240 |
Why?
|
| Ligands | 28 | 2023 | 3284 | 1.240 |
Why?
|
| Epitopes | 43 | 2023 | 2528 | 1.240 |
Why?
|
| Complementarity Determining Regions | 3 | 2016 | 154 | 1.210 |
Why?
|
| Antigens, Neoplasm | 21 | 2023 | 1997 | 1.160 |
Why?
|
| Models, Molecular | 53 | 2019 | 5403 | 1.160 |
Why?
|
| Antigens, Viral | 11 | 2014 | 995 | 1.150 |
Why?
|
| HLA-A Antigens | 5 | 2011 | 223 | 1.040 |
Why?
|
| Protein Conformation | 42 | 2019 | 3956 | 1.030 |
Why?
|
| H-2 Antigens | 11 | 2004 | 359 | 1.020 |
Why?
|
| Antigen Presentation | 15 | 2019 | 1251 | 0.990 |
Why?
|
| Immunodominant Epitopes | 4 | 2008 | 244 | 0.980 |
Why?
|
| Protein Multimerization | 6 | 2018 | 965 | 0.910 |
Why?
|
| HLA Antigens | 22 | 2017 | 1334 | 0.910 |
Why?
|
| Antibodies, Monoclonal | 114 | 2016 | 9263 | 0.900 |
Why?
|
| Membrane Glycoproteins | 26 | 2021 | 3711 | 0.890 |
Why?
|
| Protein Binding | 40 | 2024 | 9343 | 0.880 |
Why?
|
| Antigens, CD | 23 | 2017 | 4035 | 0.850 |
Why?
|
| Peptide Fragments | 24 | 2021 | 5151 | 0.840 |
Why?
|
| Mice | 135 | 2024 | 82029 | 0.830 |
Why?
|
| HIV Antibodies | 11 | 2023 | 1341 | 0.830 |
Why?
|
| HIV-1 | 17 | 2023 | 6961 | 0.820 |
Why?
|
| Antigens, Differentiation | 15 | 1995 | 921 | 0.820 |
Why?
|
| Glycoproteins | 16 | 2018 | 2202 | 0.810 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 10 | 2024 | 506 | 0.800 |
Why?
|
| AIDS Vaccines | 8 | 2022 | 900 | 0.790 |
Why?
|
| Antigens | 20 | 2023 | 1442 | 0.790 |
Why?
|
| Animals | 202 | 2024 | 169246 | 0.780 |
Why?
|
| Cell Dedifferentiation | 1 | 2022 | 125 | 0.780 |
Why?
|
| HIV Envelope Protein gp120 | 14 | 2013 | 925 | 0.780 |
Why?
|
| Protein Structure, Secondary | 15 | 2021 | 1216 | 0.760 |
Why?
|
| Interleukin-2 | 42 | 2007 | 1895 | 0.760 |
Why?
|
| Gene Products, env | 6 | 2005 | 250 | 0.730 |
Why?
|
| Protein Structure, Tertiary | 25 | 2014 | 3772 | 0.710 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2021 | 354 | 0.690 |
Why?
|
| Optical Tweezers | 5 | 2024 | 83 | 0.680 |
Why?
|
| HLA-A2 Antigen | 8 | 2019 | 207 | 0.670 |
Why?
|
| Signal Transduction | 43 | 2024 | 23645 | 0.650 |
Why?
|
| Orthomyxoviridae Infections | 5 | 2024 | 255 | 0.650 |
Why?
|
| B-Lymphocytes | 44 | 2018 | 4793 | 0.650 |
Why?
|
| Cell Adhesion | 19 | 2018 | 3096 | 0.650 |
Why?
|
| Cell Membrane | 20 | 2019 | 3655 | 0.640 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2024 | 427 | 0.610 |
Why?
|
| Cytoskeletal Proteins | 6 | 2018 | 1327 | 0.600 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 23 | 2018 | 977 | 0.590 |
Why?
|
| HLA-B Antigens | 2 | 2012 | 330 | 0.580 |
Why?
|
| Epitopes, B-Lymphocyte | 4 | 2016 | 85 | 0.580 |
Why?
|
| Cell Differentiation | 44 | 2017 | 11669 | 0.580 |
Why?
|
| Killer Cells, Natural | 25 | 2001 | 2211 | 0.570 |
Why?
|
| Genes | 19 | 1993 | 1824 | 0.570 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2017 | 452 | 0.560 |
Why?
|
| Viral Proteins | 10 | 2021 | 1802 | 0.560 |
Why?
|
| Cytotoxicity, Immunologic | 36 | 2013 | 1353 | 0.560 |
Why?
|
| Variola virus | 3 | 2007 | 12 | 0.550 |
Why?
|
| Binding Sites | 35 | 2011 | 6020 | 0.550 |
Why?
|
| Clone Cells | 61 | 1993 | 1670 | 0.540 |
Why?
|
| Neprilysin | 11 | 1995 | 487 | 0.530 |
Why?
|
| Transfection | 32 | 2013 | 5755 | 0.530 |
Why?
|
| Retroviridae Proteins | 6 | 2001 | 94 | 0.530 |
Why?
|
| Macromolecular Substances | 33 | 2003 | 1435 | 0.510 |
Why?
|
| Sequence Analysis, Protein | 5 | 2013 | 264 | 0.490 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 467 | 0.490 |
Why?
|
| Receptors, Fc | 9 | 1992 | 537 | 0.490 |
Why?
|
| Interferon-gamma | 12 | 2021 | 3160 | 0.480 |
Why?
|
| HLA-D Antigens | 7 | 2013 | 130 | 0.480 |
Why?
|
| Mice, Knockout | 21 | 2022 | 14488 | 0.480 |
Why?
|
| Growth Substances | 4 | 2005 | 759 | 0.470 |
Why?
|
| Vaccinia virus | 4 | 2009 | 328 | 0.460 |
Why?
|
| Immunoglobulin Fab Fragments | 4 | 2001 | 446 | 0.460 |
Why?
|
| Sequence Alignment | 17 | 2015 | 2179 | 0.450 |
Why?
|
| Smallpox Vaccine | 3 | 2009 | 77 | 0.450 |
Why?
|
| Carrier Proteins | 14 | 2003 | 4937 | 0.450 |
Why?
|
| Computational Biology | 11 | 2017 | 3568 | 0.440 |
Why?
|
| Sequence Homology, Amino Acid | 13 | 2015 | 2748 | 0.440 |
Why?
|
| Cell Line | 51 | 2017 | 15597 | 0.440 |
Why?
|
| Gene Expression Regulation | 13 | 2016 | 11928 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 31 | 2018 | 22379 | 0.440 |
Why?
|
| Tyrosine | 12 | 2001 | 1427 | 0.440 |
Why?
|
| Software | 11 | 2015 | 4478 | 0.420 |
Why?
|
| Conserved Sequence | 9 | 2018 | 1162 | 0.420 |
Why?
|
| Humans | 351 | 2024 | 768166 | 0.420 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2012 | 66 | 0.410 |
Why?
|
| Membrane Fusion | 2 | 2013 | 265 | 0.410 |
Why?
|
| Vaccines | 5 | 2023 | 842 | 0.410 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2012 | 79 | 0.410 |
Why?
|
| Antibodies, Neutralizing | 8 | 2023 | 2011 | 0.410 |
Why?
|
| CD4-Positive T-Lymphocytes | 13 | 2022 | 4415 | 0.410 |
Why?
|
| beta Karyopherins | 1 | 2012 | 46 | 0.400 |
Why?
|
| Base Sequence | 43 | 2012 | 12421 | 0.400 |
Why?
|
| Orthomyxoviridae | 4 | 2015 | 148 | 0.400 |
Why?
|
| Cyclophilin A | 1 | 2012 | 57 | 0.400 |
Why?
|
| Crystallography, X-Ray | 12 | 2020 | 1951 | 0.400 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2013 | 263 | 0.400 |
Why?
|
| Virus Internalization | 2 | 2013 | 504 | 0.390 |
Why?
|
| Dideoxynucleosides | 1 | 2012 | 135 | 0.390 |
Why?
|
| Mass Spectrometry | 7 | 2019 | 2202 | 0.390 |
Why?
|
| Lymphokines | 9 | 2001 | 924 | 0.380 |
Why?
|
| Databases, Protein | 5 | 2017 | 390 | 0.380 |
Why?
|
| Membrane Proteins | 13 | 2018 | 7876 | 0.370 |
Why?
|
| Mice, Transgenic | 20 | 2023 | 9561 | 0.370 |
Why?
|
| Protein Subunits | 4 | 2015 | 943 | 0.370 |
Why?
|
| Vesicular stomatitis Indiana virus | 6 | 2003 | 93 | 0.360 |
Why?
|
| Flow Cytometry | 24 | 2019 | 5902 | 0.360 |
Why?
|
| Mutagenesis, Site-Directed | 13 | 2013 | 1683 | 0.350 |
Why?
|
| Leukemia, Lymphoid | 13 | 1988 | 311 | 0.350 |
Why?
|
| Neutralization Tests | 10 | 2018 | 739 | 0.350 |
Why?
|
| Antibody Formation | 17 | 2018 | 1393 | 0.340 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2009 | 2909 | 0.340 |
Why?
|
| Antigen-Presenting Cells | 9 | 2017 | 960 | 0.330 |
Why?
|
| Semaphorins | 3 | 2018 | 96 | 0.330 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2024 | 3780 | 0.330 |
Why?
|
| Molecular Weight | 30 | 1999 | 2173 | 0.320 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 7 | 1992 | 318 | 0.320 |
Why?
|
| Lung | 5 | 2017 | 10099 | 0.320 |
Why?
|
| Clonal Deletion | 3 | 2004 | 75 | 0.320 |
Why?
|
| Genes, MHC Class II | 6 | 2013 | 433 | 0.310 |
Why?
|
| Immunologic Memory | 6 | 2017 | 1377 | 0.310 |
Why?
|
| Human papillomavirus 16 | 1 | 2010 | 268 | 0.300 |
Why?
|
| Autoimmune Diseases | 7 | 2018 | 2257 | 0.300 |
Why?
|
| Dimerization | 12 | 2005 | 887 | 0.300 |
Why?
|
| Structure-Activity Relationship | 12 | 2019 | 3055 | 0.300 |
Why?
|
| Recombinant Proteins | 19 | 2005 | 6514 | 0.300 |
Why?
|
| Keratinocytes | 1 | 2012 | 876 | 0.290 |
Why?
|
| Cloning, Molecular | 18 | 1998 | 4168 | 0.290 |
Why?
|
| Glycosylation | 12 | 2005 | 1100 | 0.290 |
Why?
|
| Surface Plasmon Resonance | 6 | 2008 | 272 | 0.290 |
Why?
|
| Cytoplasm | 9 | 2014 | 1505 | 0.280 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 399 | 0.280 |
Why?
|
| Calcium | 19 | 2015 | 5792 | 0.280 |
Why?
|
| Receptors, IgG | 7 | 1996 | 564 | 0.270 |
Why?
|
| beta 2-Microglobulin | 6 | 2004 | 330 | 0.270 |
Why?
|
| Viral Matrix Proteins | 1 | 2008 | 193 | 0.270 |
Why?
|
| Amino Acid Motifs | 7 | 2014 | 930 | 0.270 |
Why?
|
| Oligopeptides | 4 | 2001 | 1194 | 0.270 |
Why?
|
| Epitope Mapping | 6 | 2015 | 301 | 0.260 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2006 | 458 | 0.260 |
Why?
|
| Recombinant Fusion Proteins | 14 | 2004 | 3740 | 0.260 |
Why?
|
| Immunologic Deficiency Syndromes | 13 | 1985 | 549 | 0.250 |
Why?
|
| Simian immunodeficiency virus | 3 | 2013 | 814 | 0.240 |
Why?
|
| DNA-Binding Proteins | 13 | 2019 | 9615 | 0.240 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2002 | 175 | 0.240 |
Why?
|
| Proteins | 11 | 2011 | 6009 | 0.240 |
Why?
|
| Smallpox | 1 | 2005 | 43 | 0.240 |
Why?
|
| Neoplasms | 6 | 2023 | 22371 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 3 | 2018 | 4413 | 0.230 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2004 | 70 | 0.230 |
Why?
|
| Autoimmunity | 1 | 2012 | 1361 | 0.230 |
Why?
|
| Allergy and Immunology | 2 | 2019 | 175 | 0.220 |
Why?
|
| HIV Antigens | 3 | 2016 | 328 | 0.220 |
Why?
|
| Dendritic Cells | 4 | 2011 | 2747 | 0.220 |
Why?
|
| Rosette Formation | 15 | 2001 | 152 | 0.220 |
Why?
|
| Cell Separation | 21 | 2013 | 1728 | 0.220 |
Why?
|
| DNA | 26 | 2005 | 7214 | 0.220 |
Why?
|
| Database Management Systems | 1 | 2005 | 263 | 0.220 |
Why?
|
| Immunity, Cellular | 10 | 2009 | 1561 | 0.210 |
Why?
|
| Exons | 9 | 2000 | 2394 | 0.210 |
Why?
|
| Liposomes | 2 | 2018 | 790 | 0.210 |
Why?
|
| Receptors, IgE | 7 | 1996 | 375 | 0.210 |
Why?
|
| Jurkat Cells | 6 | 2014 | 740 | 0.210 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2001 | 94 | 0.210 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 2002 | 93 | 0.200 |
Why?
|
| Electron Spin Resonance Spectroscopy | 3 | 2013 | 161 | 0.200 |
Why?
|
| Models, Immunological | 4 | 2015 | 518 | 0.200 |
Why?
|
| Viral Fusion Proteins | 2 | 2004 | 100 | 0.200 |
Why?
|
| Cell Movement | 2 | 2018 | 5210 | 0.200 |
Why?
|
| Immunotherapy | 3 | 2015 | 4755 | 0.200 |
Why?
|
| Membrane Lipids | 4 | 2016 | 252 | 0.200 |
Why?
|
| Cancer Vaccines | 2 | 2023 | 1041 | 0.200 |
Why?
|
| Cytokines | 8 | 2007 | 7453 | 0.200 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2001 | 32 | 0.200 |
Why?
|
| T-Lymphocytes, Regulatory | 31 | 1985 | 3114 | 0.190 |
Why?
|
| Antibodies, Viral | 5 | 2015 | 3216 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2018 | 2892 | 0.190 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2001 | 74 | 0.190 |
Why?
|
| Immunologic Surveillance | 1 | 2002 | 93 | 0.190 |
Why?
|
| Sheep | 10 | 2010 | 1451 | 0.190 |
Why?
|
| Morpholines | 1 | 2005 | 584 | 0.190 |
Why?
|
| Lymphocyte Culture Test, Mixed | 13 | 2003 | 510 | 0.190 |
Why?
|
| Amino Acids | 3 | 2024 | 1716 | 0.190 |
Why?
|
| Integrins | 2 | 2018 | 842 | 0.190 |
Why?
|
| Cricetinae | 13 | 2004 | 2423 | 0.190 |
Why?
|
| Organ Culture Techniques | 4 | 2010 | 794 | 0.180 |
Why?
|
| Lysine | 2 | 2005 | 1000 | 0.180 |
Why?
|
| Membrane Microdomains | 2 | 2002 | 205 | 0.180 |
Why?
|
| Receptors, Virus | 3 | 1989 | 652 | 0.180 |
Why?
|
| GTP-Binding Proteins | 2 | 1998 | 948 | 0.180 |
Why?
|
| Immunoglobulins | 9 | 2016 | 855 | 0.180 |
Why?
|
| Phosphorylation | 13 | 2014 | 8317 | 0.180 |
Why?
|
| Protein-Tyrosine Kinases | 9 | 2023 | 2433 | 0.180 |
Why?
|
| Transcription, Genetic | 15 | 2002 | 7608 | 0.180 |
Why?
|
| DNA, Complementary | 5 | 2013 | 1989 | 0.180 |
Why?
|
| Picornaviridae Infections | 1 | 2021 | 96 | 0.170 |
Why?
|
| Nucleoproteins | 3 | 2010 | 110 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2000 | 1245 | 0.170 |
Why?
|
| Vaccination | 3 | 2023 | 3437 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 11 | 2005 | 1730 | 0.170 |
Why?
|
| Rhinovirus | 1 | 2021 | 209 | 0.170 |
Why?
|
| Immune System | 2 | 2007 | 799 | 0.170 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2019 | 73 | 0.170 |
Why?
|
| Mitogens | 4 | 1998 | 229 | 0.170 |
Why?
|
| Oligodeoxyribonucleotides | 8 | 1993 | 705 | 0.170 |
Why?
|
| Protein Structure, Quaternary | 3 | 2010 | 426 | 0.170 |
Why?
|
| Cell Division | 16 | 2002 | 4473 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 567 | 0.170 |
Why?
|
| HIV | 4 | 2001 | 1597 | 0.160 |
Why?
|
| User-Computer Interface | 2 | 2008 | 1407 | 0.160 |
Why?
|
| Antibody Specificity | 14 | 2004 | 1065 | 0.160 |
Why?
|
| Peptide Library | 4 | 2019 | 351 | 0.160 |
Why?
|
| Solubility | 13 | 2002 | 1083 | 0.160 |
Why?
|
| Protein Stability | 1 | 2021 | 580 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 12 | 2018 | 6231 | 0.160 |
Why?
|
| Baculoviridae | 3 | 2006 | 115 | 0.160 |
Why?
|
| Kinetics | 14 | 2001 | 6329 | 0.160 |
Why?
|
| Antibodies, Bispecific | 1 | 2022 | 204 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2005 | 4528 | 0.160 |
Why?
|
| Disulfides | 5 | 2014 | 466 | 0.160 |
Why?
|
| Antibodies | 16 | 1989 | 2421 | 0.160 |
Why?
|
| Escherichia coli | 5 | 2024 | 4214 | 0.160 |
Why?
|
| Plasma Cells | 4 | 2016 | 599 | 0.160 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 9538 | 0.150 |
Why?
|
| Cells, Cultured | 20 | 2015 | 19015 | 0.150 |
Why?
|
| Lymphocyte Cooperation | 12 | 1987 | 112 | 0.150 |
Why?
|
| Cytoskeleton | 3 | 2018 | 1179 | 0.150 |
Why?
|
| Quinazolines | 1 | 2005 | 1373 | 0.150 |
Why?
|
| Blotting, Western | 6 | 2006 | 5027 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 14 | 2010 | 6082 | 0.150 |
Why?
|
| Proteome | 2 | 2010 | 1890 | 0.150 |
Why?
|
| Fluoresceins | 4 | 1992 | 235 | 0.150 |
Why?
|
| Biological Evolution | 2 | 1994 | 1076 | 0.150 |
Why?
|
| Apoptosis | 7 | 2003 | 9523 | 0.140 |
Why?
|
| CHO Cells | 10 | 2004 | 1379 | 0.140 |
Why?
|
| Monocytes | 9 | 1999 | 2605 | 0.140 |
Why?
|
| Chromosome Mapping | 7 | 1993 | 4620 | 0.140 |
Why?
|
| Binding, Competitive | 12 | 2002 | 1142 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 451 | 0.140 |
Why?
|
| Integrin alpha Chains | 1 | 2017 | 93 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 492 | 0.140 |
Why?
|
| Immunogenetics | 2 | 2007 | 62 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 235 | 0.140 |
Why?
|
| Point Mutation | 6 | 2001 | 1596 | 0.140 |
Why?
|
| Transduction, Genetic | 3 | 2010 | 899 | 0.140 |
Why?
|
| Th1 Cells | 1 | 2002 | 1042 | 0.140 |
Why?
|
| Immune Tolerance | 8 | 1993 | 2323 | 0.140 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 966 | 0.130 |
Why?
|
| Th2 Cells | 1 | 2002 | 1078 | 0.130 |
Why?
|
| Alternative Splicing | 3 | 2001 | 1105 | 0.130 |
Why?
|
| Cross-Linking Reagents | 6 | 2005 | 693 | 0.130 |
Why?
|
| Immunoglobulin Variable Region | 3 | 1987 | 420 | 0.130 |
Why?
|
| Nucleocapsid Proteins | 2 | 2007 | 75 | 0.130 |
Why?
|
| Receptors, Interleukin-2 | 12 | 1989 | 564 | 0.130 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2021 | 454 | 0.130 |
Why?
|
| Polymorphism, Genetic | 4 | 2003 | 4249 | 0.130 |
Why?
|
| RNA, Messenger | 13 | 2012 | 12800 | 0.130 |
Why?
|
| Transcriptional Activation | 3 | 1997 | 1750 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 3814 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 874 | 0.120 |
Why?
|
| Sequence Homology, Nucleic Acid | 7 | 1992 | 1057 | 0.120 |
Why?
|
| Genome | 1 | 2003 | 1754 | 0.120 |
Why?
|
| Ion Channels | 4 | 1988 | 1043 | 0.120 |
Why?
|
| Isoantigens | 6 | 2007 | 562 | 0.120 |
Why?
|
| Restriction Mapping | 8 | 1992 | 849 | 0.120 |
Why?
|
| Gene Expression | 8 | 2012 | 7598 | 0.120 |
Why?
|
| Hematopoietic System | 1 | 1995 | 110 | 0.120 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2016 | 289 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2002 | 2575 | 0.120 |
Why?
|
| Binding Sites, Antibody | 5 | 2023 | 340 | 0.120 |
Why?
|
| Recombination, Genetic | 2 | 2016 | 1525 | 0.120 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1991 | 221 | 0.120 |
Why?
|
| Algorithms | 9 | 2013 | 14164 | 0.120 |
Why?
|
| Receptors, Antigen | 2 | 1984 | 51 | 0.120 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 542 | 0.120 |
Why?
|
| Polysaccharides | 4 | 2018 | 1024 | 0.120 |
Why?
|
| COS Cells | 3 | 2009 | 1135 | 0.120 |
Why?
|
| Cell Transformation, Viral | 5 | 1984 | 530 | 0.120 |
Why?
|
| Enterotoxins | 2 | 1993 | 366 | 0.110 |
Why?
|
| Invertebrates | 1 | 1994 | 55 | 0.110 |
Why?
|
| Spleen | 9 | 2001 | 2295 | 0.110 |
Why?
|
| Rabbits | 7 | 2007 | 4772 | 0.110 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 662 | 0.110 |
Why?
|
| Viral Envelope Proteins | 2 | 2007 | 640 | 0.110 |
Why?
|
| Caspases | 1 | 1997 | 882 | 0.110 |
Why?
|
| Microscopy, Electron | 3 | 2006 | 2560 | 0.110 |
Why?
|
| Germinal Center | 1 | 2016 | 380 | 0.110 |
Why?
|
| Databases, Genetic | 2 | 2014 | 1758 | 0.110 |
Why?
|
| Static Electricity | 3 | 2005 | 260 | 0.110 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.110 |
Why?
|
| Mutation | 15 | 2019 | 30238 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2001 | 1966 | 0.110 |
Why?
|
| Alleles | 6 | 2019 | 6894 | 0.110 |
Why?
|
| Phosphotyrosine | 5 | 1998 | 458 | 0.110 |
Why?
|
| Trypsin | 4 | 2005 | 491 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2006 | 5 | 0.110 |
Why?
|
| Circular Dichroism | 5 | 2002 | 337 | 0.110 |
Why?
|
| Substance P | 2 | 1991 | 332 | 0.110 |
Why?
|
| Blotting, Northern | 6 | 1994 | 1550 | 0.110 |
Why?
|
| Transcytosis | 1 | 2013 | 48 | 0.110 |
Why?
|
| Phenotype | 26 | 2007 | 16726 | 0.110 |
Why?
|
| Glycopeptides | 4 | 2002 | 225 | 0.110 |
Why?
|
| K562 Cells | 2 | 2013 | 644 | 0.110 |
Why?
|
| Crystallization | 4 | 2009 | 520 | 0.100 |
Why?
|
| Molecular Conformation | 3 | 2009 | 540 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 5 | 1998 | 5797 | 0.100 |
Why?
|
| Erythrocytes | 5 | 2001 | 2418 | 0.100 |
Why?
|
| Data Mining | 2 | 2015 | 563 | 0.100 |
Why?
|
| Stochastic Processes | 1 | 2013 | 360 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2012 | 4786 | 0.100 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 1991 | 381 | 0.100 |
Why?
|
| Protein Folding | 3 | 2017 | 871 | 0.100 |
Why?
|
| Lymphocytes | 5 | 1999 | 2614 | 0.100 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 3 | 2005 | 381 | 0.100 |
Why?
|
| Concanavalin A | 9 | 1986 | 190 | 0.100 |
Why?
|
| Bombesin | 1 | 1991 | 35 | 0.100 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 457 | 0.100 |
Why?
|
| History, 20th Century | 3 | 2019 | 2766 | 0.100 |
Why?
|
| Sialyltransferases | 2 | 2002 | 83 | 0.100 |
Why?
|
| Genes, MHC Class I | 1 | 2012 | 235 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 1991 | 393 | 0.100 |
Why?
|
| Amino Acid Substitution | 3 | 2007 | 1743 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 482 | 0.100 |
Why?
|
| Proline | 4 | 2003 | 455 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2002 | 283 | 0.090 |
Why?
|
| Medical Oncology | 1 | 2023 | 2346 | 0.090 |
Why?
|
| Fetus | 3 | 1993 | 1883 | 0.090 |
Why?
|
| Precipitin Tests | 3 | 2003 | 816 | 0.090 |
Why?
|
| Hydrogen Bonding | 3 | 2001 | 289 | 0.090 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 3 | 2000 | 69 | 0.090 |
Why?
|
| Virion | 1 | 2013 | 428 | 0.090 |
Why?
|
| Interleukin-12 | 3 | 2001 | 577 | 0.090 |
Why?
|
| Enkephalin, Methionine | 1 | 1990 | 26 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 996 | 0.090 |
Why?
|
| HIV Infections | 5 | 2023 | 17569 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 12 | 2009 | 2474 | 0.090 |
Why?
|
| Bivalvia | 1 | 1990 | 55 | 0.090 |
Why?
|
| DNA Primers | 4 | 2012 | 2828 | 0.090 |
Why?
|
| Genetic Variation | 6 | 2014 | 6611 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2013 | 600 | 0.090 |
Why?
|
| Aluminum Compounds | 1 | 1990 | 56 | 0.090 |
Why?
|
| Chromatography, Gel | 3 | 2001 | 636 | 0.090 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 13586 | 0.090 |
Why?
|
| Hemocytes | 1 | 1990 | 48 | 0.090 |
Why?
|
| Cross Protection | 1 | 2010 | 25 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 2 | 1999 | 1613 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 1993 | 640 | 0.090 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2010 | 110 | 0.090 |
Why?
|
| Immunity, Innate | 4 | 1994 | 3080 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 4 | 2001 | 2709 | 0.090 |
Why?
|
| Models, Biological | 5 | 2015 | 9495 | 0.080 |
Why?
|
| Antigen-Antibody Reactions | 8 | 1997 | 342 | 0.080 |
Why?
|
| Lymphocyte Count | 2 | 2003 | 794 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 1996 | 0.080 |
Why?
|
| Immunoglobulin A | 1 | 2013 | 992 | 0.080 |
Why?
|
| Polyglycolic Acid | 1 | 2011 | 408 | 0.080 |
Why?
|
| Female | 54 | 2021 | 397192 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 1 | 1991 | 419 | 0.080 |
Why?
|
| Hybrid Cells | 6 | 1989 | 421 | 0.080 |
Why?
|
| Mutagenesis | 3 | 2017 | 1228 | 0.080 |
Why?
|
| Chemokines | 1 | 2013 | 963 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2014 | 729 | 0.080 |
Why?
|
| Agammaglobulinemia | 5 | 1984 | 174 | 0.080 |
Why?
|
| Cell Fusion | 2 | 1988 | 294 | 0.080 |
Why?
|
| Immunization | 3 | 2013 | 1219 | 0.080 |
Why?
|
| Lymphocyte Transfusion | 1 | 2010 | 232 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2000 | 3590 | 0.080 |
Why?
|
| Immunoglobulin G | 13 | 2023 | 4568 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3428 | 0.080 |
Why?
|
| Receptors, CCR | 1 | 2008 | 37 | 0.080 |
Why?
|
| Viral Structural Proteins | 1 | 2009 | 93 | 0.080 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2013 | 545 | 0.080 |
Why?
|
| Rats | 9 | 2002 | 23760 | 0.080 |
Why?
|
| Autoantibodies | 4 | 2013 | 2121 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 3 | 2008 | 114 | 0.080 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2010 | 342 | 0.080 |
Why?
|
| Receptors, Cell Surface | 3 | 2003 | 2819 | 0.080 |
Why?
|
| Immunoglobulin Constant Regions | 2 | 1985 | 58 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 1512 | 0.070 |
Why?
|
| Virulence Factors | 1 | 2011 | 502 | 0.070 |
Why?
|
| Graft vs Host Reaction | 4 | 1982 | 99 | 0.070 |
Why?
|
| Mitochondria | 1 | 2001 | 3681 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 781 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 2227 | 0.070 |
Why?
|
| Papillomaviridae | 1 | 2014 | 1140 | 0.070 |
Why?
|
| Mice, Inbred Strains | 4 | 1993 | 1765 | 0.070 |
Why?
|
| Guinea Pigs | 2 | 2006 | 1310 | 0.070 |
Why?
|
| Papillomavirus Vaccines | 1 | 2014 | 497 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1989 | 323 | 0.070 |
Why?
|
| Transcription Factors | 4 | 2003 | 12168 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1972 | 0.070 |
Why?
|
| Internet | 4 | 2008 | 3110 | 0.070 |
Why?
|
| Antigens, Bacterial | 2 | 1992 | 1150 | 0.070 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2009 | 287 | 0.070 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 230 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 5 | 2001 | 6124 | 0.070 |
Why?
|
| Capsid | 2 | 1998 | 435 | 0.070 |
Why?
|
| Lectins, C-Type | 2 | 2008 | 594 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 1998 | 3445 | 0.070 |
Why?
|
| Viral Core Proteins | 1 | 2007 | 158 | 0.070 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2007 | 85 | 0.070 |
Why?
|
| Molecular Structure | 4 | 2003 | 1883 | 0.070 |
Why?
|
| Chromatography, Affinity | 4 | 1996 | 525 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 1987 | 322 | 0.070 |
Why?
|
| Pokeweed Mitogens | 7 | 1985 | 38 | 0.070 |
Why?
|
| RNA Splicing | 1 | 1991 | 905 | 0.070 |
Why?
|
| Bronchi | 1 | 2010 | 850 | 0.070 |
Why?
|
| Phosphatidylinositols | 4 | 1991 | 280 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2015 | 3703 | 0.070 |
Why?
|
| DNA, Neoplasm | 2 | 1989 | 1744 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1351 | 0.060 |
Why?
|
| Phytohemagglutinins | 7 | 1996 | 165 | 0.060 |
Why?
|
| Phospholipase C gamma | 1 | 2006 | 131 | 0.060 |
Why?
|
| Homosexuality | 2 | 1984 | 269 | 0.060 |
Why?
|
| Fluorescein | 3 | 1992 | 176 | 0.060 |
Why?
|
| Type C Phospholipases | 2 | 2000 | 287 | 0.060 |
Why?
|
| Chromosomes, Human, 13-15 | 1 | 1985 | 49 | 0.060 |
Why?
|
| Plasmids | 4 | 1992 | 2269 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2011 | 1140 | 0.060 |
Why?
|
| Thermodynamics | 3 | 2002 | 591 | 0.060 |
Why?
|
| Bacteriophages | 2 | 2004 | 382 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2007 | 3603 | 0.060 |
Why?
|
| Genetic Linkage | 4 | 1992 | 2342 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 686 | 0.060 |
Why?
|
| Probability | 1 | 2010 | 2479 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1989 | 1305 | 0.060 |
Why?
|
| Down-Regulation | 4 | 2006 | 2937 | 0.060 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1984 | 69 | 0.060 |
Why?
|
| Calcium Channels | 1 | 1989 | 623 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 6 | 1991 | 826 | 0.060 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1984 | 52 | 0.060 |
Why?
|
| Lymphatic Diseases | 2 | 1984 | 319 | 0.060 |
Why?
|
| Classification | 3 | 1979 | 128 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2003 | 393 | 0.060 |
Why?
|
| Protein Biosynthesis | 5 | 1991 | 2094 | 0.060 |
Why?
|
| Vaccinia | 1 | 2005 | 71 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2005 | 120 | 0.060 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2004 | 18 | 0.060 |
Why?
|
| src Homology Domains | 3 | 2002 | 361 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5432 | 0.060 |
Why?
|
| Blotting, Southern | 3 | 1989 | 775 | 0.060 |
Why?
|
| Retroviridae | 1 | 2007 | 846 | 0.060 |
Why?
|
| Ultracentrifugation | 2 | 2001 | 182 | 0.060 |
Why?
|
| Lymph Nodes | 5 | 2002 | 3474 | 0.060 |
Why?
|
| Umbilical Cord | 1 | 1985 | 179 | 0.060 |
Why?
|
| Octamer Transcription Factor-1 | 2 | 1994 | 30 | 0.060 |
Why?
|
| Lymphoma | 5 | 1989 | 1898 | 0.060 |
Why?
|
| Immune Sera | 2 | 1985 | 605 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 717 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 17140 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2007 | 841 | 0.060 |
Why?
|
| Host Cell Factor C1 | 2 | 1994 | 35 | 0.060 |
Why?
|
| Artificial Intelligence | 2 | 2011 | 2665 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 2486 | 0.060 |
Why?
|
| DNA, Viral | 2 | 2006 | 2204 | 0.060 |
Why?
|
| Receptors, HIV | 3 | 1989 | 159 | 0.060 |
Why?
|
| Vero Cells | 1 | 2005 | 486 | 0.060 |
Why?
|
| Interphase | 2 | 2002 | 227 | 0.060 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 525 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1524 | 0.060 |
Why?
|
| Selection, Genetic | 2 | 2001 | 877 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 615 | 0.050 |
Why?
|
| DNA Mutational Analysis | 4 | 2005 | 4120 | 0.050 |
Why?
|
| Protein Engineering | 2 | 2005 | 553 | 0.050 |
Why?
|
| Viral Vaccines | 1 | 2009 | 596 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 1981 | 306 | 0.050 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2003 | 39 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4912 | 0.050 |
Why?
|
| Leucine Zippers | 3 | 1999 | 116 | 0.050 |
Why?
|
| Luciferases | 1 | 2005 | 713 | 0.050 |
Why?
|
| Scattering, Radiation | 1 | 2005 | 489 | 0.050 |
Why?
|
| Influenza, Human | 2 | 2011 | 1541 | 0.050 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2003 | 72 | 0.050 |
Why?
|
| Genetic Vectors | 4 | 2009 | 3402 | 0.050 |
Why?
|
| Nanoparticles | 2 | 2015 | 1985 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2003 | 363 | 0.050 |
Why?
|
| Oligonucleotide Probes | 3 | 1992 | 417 | 0.050 |
Why?
|
| Vaccines, Subunit | 1 | 2023 | 159 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2009 | 3074 | 0.050 |
Why?
|
| Chromium | 1 | 2003 | 133 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 693 | 0.050 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1983 | 112 | 0.050 |
Why?
|
| Ribonucleases | 2 | 1994 | 266 | 0.050 |
Why?
|
| Male | 38 | 2021 | 364719 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 10760 | 0.050 |
Why?
|
| Isoelectric Focusing | 2 | 1996 | 149 | 0.050 |
Why?
|
| Multiple Sclerosis | 9 | 1986 | 3250 | 0.050 |
Why?
|
| Hematopoiesis | 3 | 1992 | 2059 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 610 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1988 | 2204 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 463 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 1983 | 269 | 0.050 |
Why?
|
| Protein Interaction Mapping | 2 | 2002 | 622 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.050 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 111 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2006 | 1497 | 0.050 |
Why?
|
| Chromatography | 1 | 2001 | 189 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 1896 | 0.050 |
Why?
|
| Stem Cells | 2 | 1999 | 3537 | 0.050 |
Why?
|
| Surface Properties | 1 | 2004 | 1166 | 0.050 |
Why?
|
| Neutrophils | 2 | 1991 | 3786 | 0.050 |
Why?
|
| Calorimetry | 1 | 2001 | 132 | 0.050 |
Why?
|
| Plant Proteins | 1 | 1984 | 376 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2001 | 96 | 0.050 |
Why?
|
| Melanoma | 2 | 2019 | 5706 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 697 | 0.050 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 1982 | 108 | 0.050 |
Why?
|
| Protein Renaturation | 1 | 2000 | 10 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2022 | 213 | 0.050 |
Why?
|
| Immunosorbent Techniques | 4 | 1989 | 174 | 0.050 |
Why?
|
| Chemistry | 3 | 1986 | 327 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2001 | 1751 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2001 | 258 | 0.040 |
Why?
|
| Goats | 4 | 1981 | 166 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 464 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2000 | 1207 | 0.040 |
Why?
|
| CpG Islands | 1 | 2005 | 1208 | 0.040 |
Why?
|
| Bone Marrow Cells | 3 | 1992 | 2414 | 0.040 |
Why?
|
| Chemical Phenomena | 3 | 1986 | 486 | 0.040 |
Why?
|
| RNA | 6 | 1992 | 2720 | 0.040 |
Why?
|
| Lymphopenia | 3 | 2001 | 300 | 0.040 |
Why?
|
| Haplotypes | 1 | 2007 | 2722 | 0.040 |
Why?
|
| Protein Denaturation | 1 | 2000 | 242 | 0.040 |
Why?
|
| Electron Transport Complex I | 1 | 2001 | 152 | 0.040 |
Why?
|
| Sequence Analysis | 2 | 1998 | 240 | 0.040 |
Why?
|
| Enterocytes | 1 | 2001 | 220 | 0.040 |
Why?
|
| Conalbumin | 1 | 1999 | 5 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2000 | 440 | 0.040 |
Why?
|
| Proteomics | 3 | 2014 | 3912 | 0.040 |
Why?
|
| Interleukin-4 | 4 | 1990 | 1156 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 5 | 1989 | 361 | 0.040 |
Why?
|
| Mice, Inbred AKR | 1 | 1999 | 104 | 0.040 |
Why?
|
| Lymphoid Tissue | 2 | 1995 | 445 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 2000 | 439 | 0.040 |
Why?
|
| Infectious Mononucleosis | 1 | 1980 | 133 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2007 | 4146 | 0.040 |
Why?
|
| Computer Graphics | 2 | 1992 | 344 | 0.040 |
Why?
|
| Virus Replication | 1 | 1988 | 2458 | 0.040 |
Why?
|
| Lymphocyte Depletion | 3 | 1997 | 605 | 0.040 |
Why?
|
| Immunophenotyping | 2 | 2003 | 1864 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2007 | 3623 | 0.040 |
Why?
|
| Drug Design | 1 | 2005 | 1046 | 0.040 |
Why?
|
| Superantigens | 1 | 1999 | 124 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 1560 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2065 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 1992 | 317 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2010 | 2982 | 0.040 |
Why?
|
| Immunologic Capping | 1 | 1998 | 30 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 830 | 0.040 |
Why?
|
| Antigens, Plant | 2 | 2013 | 104 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 3 | 1986 | 513 | 0.040 |
Why?
|
| Gene Deletion | 3 | 2001 | 2675 | 0.040 |
Why?
|
| Inclusion Bodies | 1 | 2000 | 278 | 0.040 |
Why?
|
| Virus Latency | 1 | 2022 | 361 | 0.040 |
Why?
|
| Antibody-Producing Cells | 3 | 1984 | 140 | 0.040 |
Why?
|
| Protein Transport | 1 | 2005 | 1951 | 0.040 |
Why?
|
| Light | 1 | 2005 | 1355 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 671 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1990 | 260 | 0.040 |
Why?
|
| Papain | 2 | 1989 | 66 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 1367 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 2003 | 2451 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 1319 | 0.040 |
Why?
|
| Immune System Diseases | 3 | 1987 | 253 | 0.040 |
Why?
|
| Gene Library | 2 | 1992 | 1064 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 478 | 0.040 |
Why?
|
| Mammals | 1 | 2024 | 1135 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 911 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 1890 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 648 | 0.040 |
Why?
|
| Transgenes | 1 | 2001 | 1016 | 0.040 |
Why?
|
| Cattle | 3 | 2002 | 3819 | 0.040 |
Why?
|
| Immunoglobulin E | 3 | 1992 | 1506 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1647 | 0.040 |
Why?
|
| Hybridomas | 2 | 2005 | 444 | 0.040 |
Why?
|
| Caspase 6 | 1 | 1997 | 15 | 0.040 |
Why?
|
| Liver | 1 | 1993 | 7577 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2007 | 2592 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1997 | 68 | 0.040 |
Why?
|
| Caspase 7 | 1 | 1997 | 51 | 0.040 |
Why?
|
| Lipid Bilayers | 1 | 2019 | 379 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2005 | 3447 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 1996 | 45 | 0.040 |
Why?
|
| Dogs | 1 | 2002 | 3845 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 1997 | 166 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 321 | 0.030 |
Why?
|
| Half-Life | 1 | 2018 | 651 | 0.030 |
Why?
|
| Antilymphocyte Serum | 5 | 1983 | 492 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1656 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1997 | 185 | 0.030 |
Why?
|
| Genotype | 2 | 2012 | 13045 | 0.030 |
Why?
|
| Gene Products, tax | 2 | 1998 | 51 | 0.030 |
Why?
|
| Phosphopeptides | 1 | 1997 | 240 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 20227 | 0.030 |
Why?
|
| Oligosaccharides | 2 | 1995 | 407 | 0.030 |
Why?
|
| Cricetulus | 2 | 1988 | 812 | 0.030 |
Why?
|
| Allergens | 1 | 1984 | 1443 | 0.030 |
Why?
|
| Cell Cycle | 4 | 1993 | 2932 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1062 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1627 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 4 | 1995 | 1703 | 0.030 |
Why?
|
| Cross Reactions | 3 | 2009 | 828 | 0.030 |
Why?
|
| Macaca mulatta | 3 | 2013 | 2363 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1998 | 639 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2013 | 5196 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1901 | 0.030 |
Why?
|
| Histones | 1 | 2006 | 2601 | 0.030 |
Why?
|
| Isoelectric Point | 2 | 1985 | 76 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2017 | 472 | 0.030 |
Why?
|
| Leukocyte Count | 5 | 1999 | 1609 | 0.030 |
Why?
|
| Cell Communication | 4 | 2003 | 1660 | 0.030 |
Why?
|
| Caspase 3 | 1 | 1997 | 730 | 0.030 |
Why?
|
| Graft Rejection | 3 | 2001 | 4492 | 0.030 |
Why?
|
| Anisotropy | 1 | 2018 | 1292 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1989 | 792 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 1997 | 539 | 0.030 |
Why?
|
| Genetic Code | 2 | 1985 | 139 | 0.030 |
Why?
|
| Lymphocytes, Null | 3 | 1983 | 13 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1998 | 2300 | 0.030 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2015 | 163 | 0.030 |
Why?
|
| Membrane Potentials | 2 | 1989 | 1090 | 0.030 |
Why?
|
| Dinitrobenzenes | 3 | 1983 | 37 | 0.030 |
Why?
|
| Time Factors | 5 | 2005 | 40218 | 0.030 |
Why?
|
| Genes, Overlapping | 1 | 1993 | 36 | 0.030 |
Why?
|
| Infant | 11 | 1985 | 36535 | 0.030 |
Why?
|
| Leukemia | 5 | 1985 | 1519 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 1985 | 2171 | 0.030 |
Why?
|
| Self Tolerance | 1 | 1994 | 122 | 0.030 |
Why?
|
| Adult | 33 | 2021 | 223646 | 0.030 |
Why?
|
| Knowledge Bases | 1 | 2014 | 97 | 0.030 |
Why?
|
| Administration, Rectal | 1 | 2013 | 69 | 0.030 |
Why?
|
| Crystallography | 2 | 2009 | 110 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2002 | 2493 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2000 | 1494 | 0.030 |
Why?
|
| Pneumonia | 1 | 2005 | 2163 | 0.030 |
Why?
|
| Quality Control | 1 | 2015 | 836 | 0.030 |
Why?
|
| Organ Specificity | 2 | 1995 | 1968 | 0.030 |
Why?
|
| Online Systems | 1 | 2013 | 182 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1992 | 305 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 3 | 1983 | 1082 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1992 | 341 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1992 | 145 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2146 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3800 | 0.020 |
Why?
|
| Receptors, Bombesin | 1 | 1991 | 27 | 0.020 |
Why?
|
| Vaccines, DNA | 1 | 2013 | 279 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1991 | 172 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1994 | 462 | 0.020 |
Why?
|
| Epithelium | 2 | 1988 | 1607 | 0.020 |
Why?
|
| Dipeptides | 1 | 1993 | 386 | 0.020 |
Why?
|
| Histamine Release | 1 | 1991 | 134 | 0.020 |
Why?
|
| L-Selectin | 1 | 1991 | 212 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 1996 | 998 | 0.020 |
Why?
|
| Lectins | 2 | 1984 | 490 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2005 | 4428 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 11095 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2013 | 619 | 0.020 |
Why?
|
| Phenylalanine | 1 | 1992 | 367 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1991 | 286 | 0.020 |
Why?
|
| Cyanogen Bromide | 1 | 1990 | 75 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1990 | 70 | 0.020 |
Why?
|
| Sezary Syndrome | 2 | 1981 | 80 | 0.020 |
Why?
|
| HLA-DR4 Antigen | 1 | 1990 | 22 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1997 | 945 | 0.020 |
Why?
|
| Leukocytes | 1 | 1998 | 2035 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1992 | 915 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1990 | 154 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1990 | 176 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10474 | 0.020 |
Why?
|
| Receptors, Transferrin | 2 | 1989 | 300 | 0.020 |
Why?
|
| Hodgkin Disease | 3 | 1983 | 1384 | 0.020 |
Why?
|
| Macrophages | 6 | 1999 | 5799 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2010 | 75 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 655 | 0.020 |
Why?
|
| Basophils | 1 | 1992 | 407 | 0.020 |
Why?
|
| Child, Preschool | 12 | 1985 | 42669 | 0.020 |
Why?
|
| Aluminum | 1 | 1990 | 150 | 0.020 |
Why?
|
| Microinjections | 1 | 1990 | 321 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2012 | 340 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 1990 | 557 | 0.020 |
Why?
|
| Fluorides | 1 | 1990 | 134 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 3044 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 498 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 1990 | 198 | 0.020 |
Why?
|
| Databases, Factual | 3 | 2015 | 8080 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 1998 | 1470 | 0.020 |
Why?
|
| Fowlpox virus | 1 | 2009 | 21 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 4427 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1990 | 383 | 0.020 |
Why?
|
| Defective Viruses | 1 | 2009 | 89 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1993 | 764 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2010 | 313 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2011 | 326 | 0.020 |
Why?
|
| Metaphase | 1 | 1989 | 143 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2627 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1991 | 660 | 0.020 |
Why?
|
| Insect Viruses | 1 | 1988 | 15 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 1988 | 245 | 0.020 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2008 | 67 | 0.020 |
Why?
|
| Chemical Precipitation | 2 | 1986 | 175 | 0.020 |
Why?
|
| Lepidoptera | 1 | 1988 | 24 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 1980 | 547 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2001 | 3007 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 455 | 0.020 |
Why?
|
| Acute Disease | 5 | 2001 | 7243 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 2682 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1990 | 562 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1995 | 975 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1997 | 2167 | 0.020 |
Why?
|
| Inositol | 1 | 1988 | 216 | 0.020 |
Why?
|
| Comet Assay | 1 | 2007 | 74 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1987 | 82 | 0.020 |
Why?
|
| Codon | 1 | 1989 | 599 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 2 | 1982 | 528 | 0.020 |
Why?
|
| Viruses | 1 | 2010 | 373 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 548 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5703 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2001 | 5107 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2010 | 659 | 0.020 |
Why?
|
| Immunoglobulin M | 4 | 1993 | 1528 | 0.020 |
Why?
|
| HLA-B7 Antigen | 1 | 1986 | 48 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2540 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 21206 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1987 | 407 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 1986 | 67 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1990 | 967 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 963 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2009 | 373 | 0.020 |
Why?
|
| Staphylococcus aureus | 2 | 1992 | 1430 | 0.020 |
Why?
|
| Genome, Human | 2 | 2005 | 4446 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1990 | 1470 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 622 | 0.020 |
Why?
|
| Prognosis | 1 | 2007 | 30010 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1987 | 228 | 0.020 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1985 | 8 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1985 | 298 | 0.020 |
Why?
|
| Temperature | 1 | 1992 | 2234 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1988 | 749 | 0.020 |
Why?
|
| Multigene Family | 1 | 1989 | 1081 | 0.020 |
Why?
|
| Oocytes | 1 | 1990 | 1172 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5804 | 0.020 |
Why?
|
| Middle Aged | 21 | 2021 | 223492 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 3 | 1987 | 3781 | 0.020 |
Why?
|
| Phorbols | 1 | 1985 | 44 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1992 | 3409 | 0.020 |
Why?
|
| Horses | 3 | 1980 | 295 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1985 | 226 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 5812 | 0.020 |
Why?
|
| Markov Chains | 1 | 2008 | 979 | 0.020 |
Why?
|
| Calcimycin | 1 | 1984 | 214 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1987 | 580 | 0.010 |
Why?
|
| Oxygen | 1 | 2016 | 4270 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1984 | 166 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18349 | 0.010 |
Why?
|
| Retroviridae Infections | 1 | 1985 | 148 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1989 | 1095 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2013 | 2872 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1385 | 0.010 |
Why?
|
| Carbohydrate Conformation | 2 | 1995 | 206 | 0.010 |
Why?
|
| Cell Fractionation | 2 | 2002 | 247 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1988 | 1534 | 0.010 |
Why?
|
| DNA Replication | 1 | 1991 | 1427 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1197 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1984 | 351 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1984 | 218 | 0.010 |
Why?
|
| Desmosomes | 1 | 1984 | 73 | 0.010 |
Why?
|
| Burkitt Lymphoma | 2 | 1984 | 338 | 0.010 |
Why?
|
| Cytosine | 1 | 2005 | 213 | 0.010 |
Why?
|
| Carbohydrate Sequence | 2 | 1995 | 411 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4580 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1984 | 171 | 0.010 |
Why?
|
| Moths | 1 | 2004 | 82 | 0.010 |
Why?
|
| Autoradiography | 1 | 1985 | 727 | 0.010 |
Why?
|
| Immunity | 1 | 2010 | 1003 | 0.010 |
Why?
|
| Solutions | 1 | 2004 | 409 | 0.010 |
Why?
|
| Complement System Proteins | 3 | 1984 | 738 | 0.010 |
Why?
|
| Hemolytic Plaque Technique | 2 | 1982 | 59 | 0.010 |
Why?
|
| Sjogren's Syndrome | 2 | 1985 | 240 | 0.010 |
Why?
|
| Viral Load | 1 | 2013 | 3396 | 0.010 |
Why?
|
| Pollen | 1 | 1984 | 80 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8128 | 0.010 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 2040 | 0.010 |
Why?
|
| Inflammation | 2 | 2019 | 10873 | 0.010 |
Why?
|
| Mast Cells | 1 | 1991 | 1406 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1985 | 609 | 0.010 |
Why?
|
| Tetanus Toxoid | 2 | 1981 | 188 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4887 | 0.010 |
Why?
|
| Ovary | 1 | 1988 | 965 | 0.010 |
Why?
|
| Aging | 3 | 1996 | 8744 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1984 | 289 | 0.010 |
Why?
|
| Peanut Agglutinin | 1 | 1982 | 19 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1985 | 587 | 0.010 |
Why?
|
| DNA Damage | 1 | 1992 | 2469 | 0.010 |
Why?
|
| Interleukins | 1 | 1987 | 796 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2002 | 91 | 0.010 |
Why?
|
| Granulocytes | 1 | 1984 | 551 | 0.010 |
Why?
|
| Keratins | 1 | 1984 | 499 | 0.010 |
Why?
|
| Lymphatic System | 1 | 1984 | 251 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1985 | 648 | 0.010 |
Why?
|
| Prednisolone | 1 | 1983 | 326 | 0.010 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1981 | 8 | 0.010 |
Why?
|
| Mitomycins | 1 | 1981 | 46 | 0.010 |
Why?
|
| Thymus Neoplasms | 1 | 1984 | 274 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1987 | 998 | 0.010 |
Why?
|
| Adolescent | 10 | 1985 | 89169 | 0.010 |
Why?
|
| Neurons | 1 | 2001 | 9514 | 0.010 |
Why?
|
| Culture Media | 1 | 1984 | 898 | 0.010 |
Why?
|
| Snails | 1 | 1981 | 21 | 0.010 |
Why?
|
| IgA Deficiency | 1 | 1981 | 39 | 0.010 |
Why?
|
| Antigens, Heterophile | 1 | 1982 | 71 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2001 | 85 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 1981 | 64 | 0.010 |
Why?
|
| Hypergammaglobulinemia | 1 | 1981 | 71 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 2001 | 186 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1983 | 716 | 0.010 |
Why?
|
| Anemia, Aplastic | 2 | 1984 | 231 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1985 | 1034 | 0.010 |
Why?
|
| Lepromin | 1 | 1980 | 8 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1991 | 3228 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3628 | 0.010 |
Why?
|
| Capsid Proteins | 1 | 2004 | 468 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 2001 | 297 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1987 | 2916 | 0.010 |
Why?
|
| Primates | 1 | 1983 | 520 | 0.010 |
Why?
|
| Chimera | 1 | 2001 | 454 | 0.010 |
Why?
|
| Leprosy | 1 | 1980 | 125 | 0.010 |
Why?
|
| Syndrome | 2 | 1984 | 3272 | 0.010 |
Why?
|
| Child | 14 | 1984 | 80917 | 0.010 |
Why?
|
| Mycosis Fungoides | 1 | 1981 | 169 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1983 | 693 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 3671 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 748 | 0.010 |
Why?
|
| Eosinophils | 1 | 1984 | 952 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1988 | 4176 | 0.010 |
Why?
|
| Isoantibodies | 2 | 1981 | 681 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1979 | 98 | 0.010 |
Why?
|
| Polymers | 1 | 1986 | 1630 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2001 | 825 | 0.010 |
Why?
|
| Sarcoma, Kaposi | 1 | 1982 | 376 | 0.010 |
Why?
|
| Intestines | 1 | 1988 | 1909 | 0.010 |
Why?
|
| Pregnancy | 3 | 1993 | 30256 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1999 | 248 | 0.010 |
Why?
|
| Endocytosis | 1 | 2003 | 956 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1980 | 283 | 0.010 |
Why?
|
| Bone Marrow | 3 | 1984 | 2935 | 0.010 |
Why?
|
| Boston | 1 | 2011 | 9374 | 0.010 |
Why?
|
| Phylogeny | 2 | 2002 | 2843 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1982 | 1252 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2000 | 393 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41754 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1985 | 1408 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1983 | 4262 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2001 | 486 | 0.010 |
Why?
|
| Fluorescence | 1 | 1980 | 756 | 0.010 |
Why?
|
| Aged | 8 | 2019 | 171504 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1983 | 2227 | 0.010 |
Why?
|
| Transplantation, Homologous | 3 | 1983 | 4833 | 0.010 |
Why?
|
| Nucleotidyltransferases | 1 | 1979 | 242 | 0.010 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1982 | 539 | 0.010 |
Why?
|
| Receptors, Interleukin-12 | 1 | 1996 | 26 | 0.010 |
Why?
|
| Antigens, T-Independent | 1 | 1996 | 20 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3573 | 0.010 |
Why?
|
| Gestational Age | 1 | 1985 | 3621 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 1980 | 691 | 0.010 |
Why?
|
| Biosensing Techniques | 1 | 2002 | 662 | 0.010 |
Why?
|
| Biological Transport | 1 | 2000 | 2085 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1980 | 718 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1985 | 2124 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 243 | 0.010 |
Why?
|
| Mitosis | 1 | 1980 | 1178 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 60066 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1979 | 1230 | 0.010 |
Why?
|
| Leukopenia | 2 | 1985 | 212 | 0.010 |
Why?
|
| Acetylglucosamine | 1 | 1995 | 189 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2000 | 1611 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1986 | 355 | 0.010 |
Why?
|
| Cell Survival | 1 | 1982 | 5777 | 0.010 |
Why?
|
| Drosophila | 1 | 1999 | 1513 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 9419 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1991 | 216 | 0.010 |
Why?
|
| Sepharose | 1 | 1991 | 102 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1992 | 866 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1992 | 766 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1984 | 3049 | 0.010 |
Why?
|
| Thrombocytopenia | 3 | 1985 | 1179 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 2 | 1981 | 320 | 0.010 |
Why?
|
| Brain | 5 | 1983 | 27360 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1980 | 2846 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1983 | 4206 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2001 | 3514 | 0.010 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 1990 | 94 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 1990 | 416 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1980 | 1662 | 0.010 |
Why?
|
| Ovalbumin | 2 | 1981 | 677 | 0.010 |
Why?
|
| Homeostasis | 1 | 1980 | 3348 | 0.010 |
Why?
|
| Oligodendroglia | 2 | 1983 | 540 | 0.000 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1993 | 1169 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1985 | 26422 | 0.000 |
Why?
|
| Particle Accelerators | 1 | 1987 | 173 | 0.000 |
Why?
|
| Pattern Recognition, Automated | 1 | 1993 | 993 | 0.000 |
Why?
|
| Plant Lectins | 1 | 1986 | 103 | 0.000 |
Why?
|
| Fabaceae | 1 | 1986 | 103 | 0.000 |
Why?
|
| Plants, Medicinal | 1 | 1986 | 167 | 0.000 |
Why?
|
| Deltaretrovirus | 1 | 1985 | 162 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1627 | 0.000 |
Why?
|
| Dinitrophenols | 1 | 1984 | 56 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1979 | 9384 | 0.000 |
Why?
|
| gamma-Globulins | 1 | 1983 | 119 | 0.000 |
Why?
|
| Xerostomia | 1 | 1984 | 94 | 0.000 |
Why?
|
| Aotus trivirgatus | 1 | 1983 | 35 | 0.000 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1983 | 45 | 0.000 |
Why?
|
| Lemur | 1 | 1983 | 5 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1983 | 213 | 0.000 |
Why?
|
| Random Allocation | 1 | 1987 | 2396 | 0.000 |
Why?
|
| Skin Ulcer | 1 | 1984 | 130 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1983 | 699 | 0.000 |
Why?
|
| Saimiri | 1 | 1983 | 337 | 0.000 |
Why?
|
| Convalescence | 1 | 1982 | 107 | 0.000 |
Why?
|
| Herpes Zoster | 1 | 1984 | 252 | 0.000 |
Why?
|
| Periodic Acid | 1 | 1981 | 17 | 0.000 |
Why?
|
| Galactose Oxidase | 1 | 1981 | 12 | 0.000 |
Why?
|
| Borohydrides | 1 | 1981 | 31 | 0.000 |
Why?
|
| Chickens | 1 | 1983 | 845 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 863 | 0.000 |
Why?
|
| Muscular Diseases | 1 | 1985 | 553 | 0.000 |
Why?
|
| Central Nervous System Diseases | 1 | 1985 | 520 | 0.000 |
Why?
|
| Mycobacterium leprae | 1 | 1980 | 95 | 0.000 |
Why?
|
| Neuraminidase | 1 | 1981 | 195 | 0.000 |
Why?
|
| Splenectomy | 1 | 1981 | 392 | 0.000 |
Why?
|
| Capillaries | 1 | 1983 | 755 | 0.000 |
Why?
|
| Prednisone | 1 | 1984 | 1567 | 0.000 |
Why?
|
| Leukemia, Experimental | 1 | 1979 | 225 | 0.000 |
Why?
|
| Hypothyroidism | 1 | 1984 | 667 | 0.000 |
Why?
|
| Autopsy | 1 | 1983 | 1011 | 0.000 |
Why?
|
| Cell Count | 1 | 1983 | 1832 | 0.000 |
Why?
|
| Plasmacytoma | 1 | 1979 | 170 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1984 | 1599 | 0.000 |
Why?
|
| Twins, Monozygotic | 1 | 1979 | 472 | 0.000 |
Why?
|
| Neuroglia | 1 | 1983 | 960 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1984 | 1309 | 0.000 |
Why?
|
| Radiotherapy | 1 | 1984 | 1502 | 0.000 |
Why?
|
| Mediastinal Neoplasms | 1 | 1980 | 403 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1987 | 8542 | 0.000 |
Why?
|
| Antibodies, Bacterial | 1 | 1981 | 1479 | 0.000 |
Why?
|
| Aorta | 1 | 1983 | 2045 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1985 | 1944 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 1987 | 39348 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1985 | 2100 | 0.000 |
Why?
|
| Tissue Donors | 1 | 1979 | 2381 | 0.000 |
Why?
|
| Age Factors | 1 | 1983 | 18412 | 0.000 |
Why?
|
| Skin | 1 | 1979 | 4503 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1982 | 20760 | 0.000 |
Why?
|